Feb 18, 2020 7:00am EST FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes
Feb 11, 2020 1:30pm EST 22nd Century Group’s FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry
Dec 23, 2019 3:39pm EST 22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
Dec 17, 2019 1:34pm EST FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes
Dec 03, 2019 5:24pm EST 22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.
